157 related articles for article (PubMed ID: 22202095)
1. Anti-Thomsen-Friedenreich-Ag (anti-TF-Ag) potential for cancer therapy.
Almogren A; Abdullah J; Ghapure K; Ferguson K; Glinsky VV; Rittenhouse-Olson K
Front Biosci (Schol Ed); 2012 Jan; 4(3):840-63. PubMed ID: 22202095
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of spontaneous breast cancer metastasis by anti-Thomsen-Friedenreich antigen monoclonal antibody JAA-F11.
Heimburg J; Yan J; Morey S; Glinskii OV; Huxley VH; Wild L; Klick R; Roy R; Glinsky VV; Rittenhouse-Olson K
Neoplasia; 2006 Nov; 8(11):939-48. PubMed ID: 17132226
[TBL] [Abstract][Full Text] [Related]
3. Development, characterization, and immunotherapeutic use of peptide mimics of the Thomsen-Friedenreich carbohydrate antigen.
Heimburg-Molinaro J; Almogren A; Morey S; Glinskii OV; Roy R; Wilding GE; Cheng RP; Glinsky VV; Rittenhouse-Olson K
Neoplasia; 2009 Aug; 11(8):780-92. PubMed ID: 19649208
[TBL] [Abstract][Full Text] [Related]
4. Jaa-f11: extending the life of mice with breast cancer.
Rittenhouse-Olson K
Expert Opin Biol Ther; 2007 Jul; 7(7):923-8. PubMed ID: 17665983
[TBL] [Abstract][Full Text] [Related]
5. Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and InVitro Efficacy Analysis.
Tati S; Fisk JC; Abdullah J; Karacosta L; Chrisikos T; Philbin P; Morey S; Ghazal D; Zazala F; Jessee J; Quataert S; Koury S; Moreno D; Eng JY; Glinsky VV; Glinskii OV; Sesay M; Gebhard AW; Birthare K; Olson JR; Rittenhouse-Olson K
Neoplasia; 2017 Sep; 19(9):716-733. PubMed ID: 28830009
[TBL] [Abstract][Full Text] [Related]
6. Preclinical studies with JAA-F11 anti-Thomsen-Friedenreich monoclonal antibody for human breast cancer.
Ferguson K; Yadav A; Morey S; Abdullah J; Hrysenko G; Eng JY; Sajjad M; Koury S; Rittenhouse-Olson K
Future Oncol; 2014 Feb; 10(3):385-99. PubMed ID: 24559446
[TBL] [Abstract][Full Text] [Related]
7. Tumor immunolocalization using 124 I-iodine-labeled JAA-F11 antibody to Thomsen-Friedenreich alpha-linked antigen.
Chaturvedi R; Heimburg J; Yan J; Koury S; Sajjad M; Abdel-Nabi HH; Rittenhouse-Olson K
Appl Radiat Isot; 2008 Mar; 66(3):278-87. PubMed ID: 17890096
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy of the humanized JAA-F11 anti-Thomsen-Friedenreich antibody constructs H2aL2a and H3L3 in human breast and lung cancer xenograft models.
Ghazal D; Zalzala F; Fisk JC; Tati S; Karacosta LG; Morey S; Olson JR; Quataert S; Dy GK; Rittenhouse-Olson K
Oncotarget; 2022 Oct; 13():1155-1164. PubMed ID: 36264086
[TBL] [Abstract][Full Text] [Related]
9. Profiling of Naturally Occurring Antibodies to the Thomsen-Friedenreich Antigen in Health and Cancer: The Diversity and Clinical Potential.
Kurtenkov O
Biomed Res Int; 2020; 2020():9747040. PubMed ID: 32280709
[TBL] [Abstract][Full Text] [Related]
10. Computational screening of the human TF-glycome provides a structural definition for the specificity of anti-tumor antibody JAA-F11.
Tessier MB; Grant OC; Heimburg-Molinaro J; Smith D; Jadey S; Gulick AM; Glushka J; Deutscher SL; Rittenhouse-Olson K; Woods RJ
PLoS One; 2013; 8(1):e54874. PubMed ID: 23365681
[TBL] [Abstract][Full Text] [Related]
11. Active immunization of human ovarian cancer patients against a common carcinoma (Thomsen-Friedenreich) determinant using a synthetic carbohydrate antigen.
MacLean GD; Bowen-Yacyshyn MB; Samuel J; Meikle A; Stuart G; Nation J; Poppema S; Jerry M; Koganty R; Wong T
J Immunother (1991); 1992 May; 11(4):292-305. PubMed ID: 1599915
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies and synthetic tumor-associated glycoconjugates in the study of the expression of Thomsen-Friedenreich-like and Tn-like antigens on human cancers.
Longenecker BM; Willans DJ; MacLean GD; Selvaraj S; Suresh MR; Noujaim AA
J Natl Cancer Inst; 1987 Mar; 78(3):489-96. PubMed ID: 3469463
[TBL] [Abstract][Full Text] [Related]
13. Preclinical Analysis of JAA-F11, a Specific Anti-Thomsen-Friedenreich Antibody via Immunohistochemistry and In Vivo Imaging.
Karacosta LG; Fisk JC; Jessee J; Tati S; Turner B; Ghazal D; Ludwig R; Johnson H; Adams J; Sajjad M; Koury S; Roy R; Olson JR; Rittenhouse-Olson K
Transl Oncol; 2018 Apr; 11(2):450-466. PubMed ID: 29477636
[TBL] [Abstract][Full Text] [Related]
14. Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin.
Campbell BJ; Finnie IA; Hounsell EF; Rhodes JM
J Clin Invest; 1995 Feb; 95(2):571-6. PubMed ID: 7860740
[TBL] [Abstract][Full Text] [Related]
15. Immunoreactivity of monoclonal antibody BW835 represents a marker of progression and prognosis in early gastric cancer.
Baldus SE; Zirbes TK; Glossmann J; Fromm S; Hanisch FG; Mönig SP; Schröder W; Schneider PM; Flucke U; Karsten U; Thiele J; Hölscher AH; Dienes HP
Oncology; 2001; 61(2):147-55. PubMed ID: 11528254
[TBL] [Abstract][Full Text] [Related]
16. A tandem enzymatic approach for detecting and imaging tumor-associated Thomsen-Friedenreich antigen disaccharide.
Li Q; Li Z; Duan X; Yi W
J Am Chem Soc; 2014 Sep; 136(36):12536-9. PubMed ID: 25157422
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of proliferation in human colon cancer cells by human monoclonal antibodies against the TF antigen (galactose beta1-3 N-acetyl-galactosamine).
Yu LG; Jansson B; Fernig DG; Milton JD; Smith JA; Gerasimenko OV; Jones M; Rhodes JM
Int J Cancer; 1997 Nov; 73(3):424-31. PubMed ID: 9359491
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of liver metastases from neuraminidase-treated colon 26 cells by an anti-Thomsen-Friedenreich-specific monoclonal antibody.
Shigeoka H; Karsten U; Okuno K; Yasutomi M
Tumour Biol; 1999; 20(3):139-46. PubMed ID: 10213921
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of the Thomsen-Friedenreich antigen.
MacLean GD; Longenecker BM
Semin Cancer Biol; 1991 Dec; 2(6):433-9. PubMed ID: 1810470
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of Thomsen-Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients.
Schindlbeck C; Jeschke U; Schulze S; Karsten U; Janni W; Rack B; Krajewski S; Sommer H; Friese K
Breast Cancer Res Treat; 2007 Jan; 101(1):17-25. PubMed ID: 16807671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
